Riverhead Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$2.77M Buy
37,785
+6,537
+21% +$479K 0.1% 257
2019
Q2
$1.92M Buy
31,248
+5,325
+21% +$328K 0.07% 348
2019
Q1
$1.65M Buy
25,923
+1,776
+7% +$113K 0.07% 359
2018
Q4
$1.23M Buy
24,147
+2,223
+10% +$114K 0.06% 390
2018
Q3
$1.27M Sell
21,924
-240
-1% -$13.9K 0.05% 425
2018
Q2
$1.08M Buy
22,164
+1,695
+8% +$82.3K 0.04% 446
2018
Q1
$952K Sell
20,469
-2,196
-10% -$102K 0.04% 442
2017
Q4
$851K Buy
22,665
+2,730
+14% +$103K 0.04% 476
2017
Q3
$726K Sell
19,935
-10,587
-35% -$386K 0.03% 487
2017
Q2
$1.2M Sell
30,522
-15,528
-34% -$612K 0.06% 347
2017
Q1
$1.44M Sell
46,050
-91,281
-66% -$2.86M 0.08% 299
2016
Q4
$4.29M Sell
137,331
-600
-0.4% -$18.7K 0.26% 100
2016
Q3
$5.54M Buy
137,931
+105,096
+320% +$4.22M 0.36% 64
2016
Q2
$50K Sell
32,835
-749,652
-96% -$1.14M ﹤0.01% 1325
2016
Q1
$23M Buy
782,487
+182,559
+30% +$5.37M 0.32% 74
2015
Q4
$15.8M Buy
599,928
+288,654
+93% +$7.6M 0.23% 110
2015
Q3
$7.38M Buy
311,274
+24,936
+9% +$591K 0.12% 244
2015
Q2
$6.8M Buy
286,338
+4,836
+2% +$115K 0.1% 268
2015
Q1
$6.68M Sell
281,502
-1,344
-0.5% -$31.9K 0.1% 265
2014
Q4
$6.01M Buy
282,846
+137,838
+95% +$2.93M 0.09% 275
2014
Q3
$2.47M Buy
145,008
+51,252
+55% +$873K 0.04% 417
2014
Q2
$1.34M Buy
93,756
+10,608
+13% +$152K 0.03% 505
2014
Q1
$1.03M Buy
83,148
+5,886
+8% +$72.8K 0.02% 503
2013
Q4
$847K Buy
77,262
+41,262
+115% +$452K 0.02% 466
2013
Q3
$418K Hold
36,000
0.01% 419
2013
Q2
$403K Buy
+36,000
New +$403K 0.01% 435